This type of comprehensive studies are crucial to continue disentangling the beneficial (or detrimental) role(s) of TREM2 and CD33, and respective intracellular signalling pathways, in murine models of amyloidosis, tauopathy, or mixed pathologies [134, 151, 163–165]. The gene discussed is CD33; the disease is amyloidosis.